Article Text

Download PDFPDF
5-HT1A receptor-mediated attenuation of heat hyperalgesia and mechanical allodynia by chrysin in mice with experimental mononeuropathy
  1. Jiayi Wu1,
  2. Yangui Wang2,
  3. Wugeng Cui1,
  4. Wenhua Zhou1 and
  5. Xin Zhao1
  1. 1Department of Pharmacology, Ningbo University, School of Medical Science, Ningbo, China
  2. 2Department of Geriatrics, Hunan Provincial People’s Hospital, Changsha, China
  1. Correspondence to Dr Xin Zhao, Ningbo University, Ningbo, China; zhaoxin{at}nbu.edu.cn

Abstract

Background Persistent neuropathic pain poses a health problem, for which effective therapy or antidote is in dire need. This work aimed to investigate the pain-relieving effect of chrysin, a natural flavonoid with monoamine oxidase inhibitory activity, in an experimental model of neuropathic pain and elucidate mechanism(s).

Methods Chronic constriction injury (CCI) was produced by loose ligation of sciatic nerve in mice. The pain-related behaviors were examined using von Frey test and Hargreaves test. The serotonin-related mechanisms were investigated by serotonin depletion with p-chlorophenylalanine (PCPA) and antagonist tests in vivo and in vitro.

Results Repeated treatment of CCI mice with chrysin (orally, two times per day for 2 weeks) ameliorated heat hyperalgesia and mechanical allodynia in a dose-dependent fashion (3–30 mg/kg). The chrysin-triggered pain relief seems serotonergically dependent, since its antihyperalgesic and antiallodynic actions were abolished by chemical depletion of serotonin by PCPA, whereas potentiated by 5-hydroxytryptophan (a precursor of 5-HT). Consistently, chrysin-treated neuropathic mice showed enhanced levels of spinal monoamines especially 5-HT, with depressed monoamine oxidase activity. Moreover, chrysin-evoked pain relief was preferentially counteracted by 5-HT1A receptor antagonist WAY-100635 delivered systematically or spinally. In vitro, chrysin (0.1–10 nM) increased the maximum effect (Emax, shown as stimulation of [35S] GTPγS binding) of 8-OH-DPAT, a 5-HT1A agonist. Beneficially, chrysin was able to correct comorbid behavioral symptoms of depression and anxiety evoked by neuropathic pain, without causing hypertensive crisis (known as ‘cheese reaction’).

Conclusion These findings confirm the antihyperalgesic and antiallodynic efficacies of chrysin, with spinal 5-HT1A receptors being critically engaged.

  • animal experimentation
  • pharmacology
  • chronic pain
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JW and XZ designed the study. JW, YW and WZ performed the experiments. WC analyzed the data. XZ wrote the manuscript and supervised the whole study.

  • Funding This project was sponsored by Natural Science Foundation of Zhejiang Province (LY18H310006), Innovative Research Team of Ningbo (2015C110026), K. C. Wong Magna Fund in Ningbo University, Key Research and Development Project of Hunan Provincial Science and Technology Department (2017SK2152) and XinXin Heart (SIP) Foundation (2018-CCA-CMVD-02).

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available on reasonable request. All data relevant to the study are included in the article or uploaded as online supplementary information. All data relevant to the study are included in the article or uploaded as online supplementary information and data are available on reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.